» Articles » PMID: 37782756

ATG9A Modulated by MiR-195-5p Can Boost the Malignant Progression of Cervical Cancer Cells

Overview
Journal Epigenetics
Specialty Genetics
Date 2023 Oct 2
PMID 37782756
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer (CC) is a major public health problem, and its molecular mechanism requires further investigation. The goal of this study was to determine the role of miR-195-5p and the autophagy-related protein ATG9A in tumour metastasis, epithelial - mesenchymal transition (EMT), apoptosis, and autophagy of CC cells. Using bioinformatics analysis, we predicted ATG9A as a downstream target gene of miR-195-5p, an integral membrane protein required for autophagosome formation and involved in tumorigenesis. Next, western blotting and Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) showed that upregulation of miR-195-5p decreased protein and mRNA expression of ATG9A, and downregulation of miR-195-5p promoted ATG9A protein and mRNA expression. In addition, detection of the dual luciferase reporter gene further indicated ATG9A is a direct downstream target gene of miR-195-5p. Finally, the effects of miR-195-5p and ATG9A on CC cell proliferation, migration, invasion, EMT, autophagy, and apoptosis were evaluated . Our results showed that upregulation of miR-195-5p not only inhibits proliferation, migration, and the EMT of CC cells, but also induces apoptosis and autophagy. Conversely, downregulation of miR-195-5p increased malignant metastasis and the EMT of CC cells, and inhibited apoptosis as well as autophagy. In addition, miR-195-5p targeted and negatively regulated ATG9A, and rescue experiments suggested that overexpression of ATG9A could partially abolish miR-195-5p-mediated suppression of CC cells. Our findings improve our understanding of the mechanism of action of miR-195-5p in the malignant behaviour of CC. miR-195-5p is likely to be a promising cancer suppressor gene, which provides clinical evidence for targeted therapy of CC.

Citing Articles

lncRNA ACVR2B-AS1 modulates thyroid cancer progression by regulating miR-195-5p.

Qin T, Lei C, Xiao H, Yang J, Luo Q, Hu L Discov Oncol. 2025; 16(1):267.

PMID: 40045085 PMC: 11883067. DOI: 10.1007/s12672-025-01993-7.


N6-methyladenosine (m6A) RNA methylation of LncRNA LINC01214 accelerates the progression of non-small cell lung cancer (NSCLC) by targeting miR-195-5p/ROCK1 axis.

Sun X, Liu C, Chen W, Chen M, Tian H Cytotechnology. 2025; 77(1):29.

PMID: 39744313 PMC: 11685359. DOI: 10.1007/s10616-024-00686-3.


Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer.

Karunakara S, Eswaran S, Mallya S, Suresh P, Chakrabarty S, Kabekkodu S BMC Res Notes. 2024; 17(1):217.

PMID: 39095857 PMC: 11297691. DOI: 10.1186/s13104-024-06876-8.

References
1.
Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

2.
Orsi A, Razi M, Dooley H, Robinson D, Weston A, Collinson L . Dynamic and transient interactions of Atg9 with autophagosomes, but not membrane integration, are required for autophagy. Mol Biol Cell. 2012; 23(10):1860-73. PMC: 3350551. DOI: 10.1091/mbc.E11-09-0746. View

3.
Liu X, Zhou Y, Ning Y, Gu H, Tong Y, Wang N . MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1. Onco Targets Ther. 2020; 13:931-944. PMC: 6996614. DOI: 10.2147/OTT.S227826. View

4.
Ventura A, Jacks T . MicroRNAs and cancer: short RNAs go a long way. Cell. 2009; 136(4):586-91. PMC: 3910108. DOI: 10.1016/j.cell.2009.02.005. View

5.
Chaffer C, San Juan B, Lim E, Weinberg R . EMT, cell plasticity and metastasis. Cancer Metastasis Rev. 2016; 35(4):645-654. DOI: 10.1007/s10555-016-9648-7. View